Detalles de la búsqueda
1.
Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11).
Cancer
; 128(4): 778-787, 2022 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34705268
2.
Superselective vesical artery embolization for intractable bladder hemorrhage related to pelvic malignancy.
Acta Radiol
; 62(9): 1229-1237, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32854526
3.
Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
Cancer
; 126(20): 4521-4531, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32749686
4.
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
Oncologist
; 25(3): e502-e511, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162799
5.
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
BMC Cancer
; 20(1): 813, 2020 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32854649
6.
Interference with daily functioning by breakthrough pain in patients with cancer.
Support Care Cancer
; 28(11): 5177-5183, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32056013
7.
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study.
Lancet Oncol
; 20(12): 1681-1690, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31587882
8.
Neutrophil-to-lymphocyte ratio and risk of lung cancer mortality in a low-risk population: A cohort study.
Int J Cancer
; 145(12): 3267-3275, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31454064
9.
Impact of Epidermal Growth Factor Receptor Mutation on Clinical Outcomes of Nintedanib Plus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer from the Korean Named Patient Program.
Oncology
; 96(1): 51-58, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30368503
10.
Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.
Support Care Cancer
; 27(5): 1945-1949, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30218188
11.
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.
Br J Cancer
; 118(9): 1169-1175, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29576622
12.
Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial.
Oncologist
; 22(11): 1354-1361, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28687626
13.
Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis.
Eur Radiol
; 27(6): 2333-2347, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27595836
14.
Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide.
Eur J Haematol
; 92(6): 478-84, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24460733
15.
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs.
BMC Health Serv Res
; 14: 595, 2014 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25432511
16.
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.
Cancer Res Treat
; 56(1): 37-47, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37475136
17.
Evaluating the effect of a mobile-based symptom monitoring system for improving physical function in patients with cancer during chemotherapy: study protocol for a multicentre randomised controlled trial.
BMJ Open
; 14(5): e080976, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38692724
18.
Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study.
Oral Oncol
; 151: 106739, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458039
19.
Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201.
Lung Cancer
; 190: 107509, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38432025
20.
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.
Cancer Res Treat
; 56(1): 48-60, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402411